HomeNews

News

One shot Sputnik Light has high safety and 93.5% efficacy against COVID

The heterogeneous boosting approach was at the core of Sputnik V, the world’s first registered vaccine against coronavirus.

Grindeks has reached record high turnover and profit in the first half of 2021

The sales of final dosage forms in the first half of 2021 totaled 109,5 million euros and compared to the first half of 2020 increased by 21.9 million euros.

Hanmi Science has completed the development of six types of raw materials for mRNA vaccines

Hanmi Science has formed a consortium with ST Pharm and GC Green Cross to secure and commercialize domestic mRNA vaccine technology by 2022.

Artificial intelligence in medicine regulation

Regulators may need to apply a risk-based approach to assessing and regulating AI, which could be informed through exchange and collaboration in ICMRA.

Over 38 tonnes of medicines from Russia arrive to Cuba

This assistance is of great importance for countering the consequences of the pandemic, as well as at a time when the U.S. is tightening the blockade against country.

No deaths linked to EpiVacCorona vaccine registered in Russia

EpiVacCorona is a single-dose synthetic peptide vaccine against COVID-19 developed by the Vector State Research Center of Virology and Biotechnology.
spot_img

Expert Articles

spot_img